个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
首都医科大学药学院药理学系，副教授，硕士生导师。获得北京大学医学部学士学位，美国Universityof Kentucky 博士学位。主要从事心血管药理学的研究，侧重于通过纳米制剂改善心血管药物的药理效应，并进行相关机制的探索。目前主要研究方向是对心肌缺血的诊断试剂和治疗药物进行研发和机制研究。主持过国家级、省部级和北京市教委资助的多项课题。已发表SCI论文20余篇，其中一作/通讯作者（含并列）SCI论文10余篇。曾参与多本药理学教材编著。现为多本SCI杂志审稿人。
北京市教育委员会, 科技计划一般项目, KM202010025028, 新型碳量子点在心梗诊断和靶向给药中的 应用, 2020-01 至 2022-12, 15万元, 在研, 主持
1. RGD-modified ZIF-8nanoparticles as a drug carrier for MR imaging and targeted drug delivery in myocardialinfarction, Yingxu Li; Maisituremu Tuerhan; Bing Li; Shuangling Chen; YujiWang; Yuanyuan Zheng; Nanomedicine (Lond), 2024, 19(18-20): 1585-1600
2. VEGF mimetic peptide conjugatednanoparticles for magnetic resonance imaging and therapy of myocardialinfarction, Bing Li; Yingxu Li; Shuangling Chen; Yuji Wang; Yuanyuan Zheng; Journalof Controlled Release, 2023, 360: 44-56
3. Albumin-templated manganese carbonatenanoparticles for precise magnetic resonance imaging of acute myocardialinfarction. Li B, Han L, Wang H, et al. J Biomater Appl. 2022.
4. Functional Calsequestrin-1 Is Expressedin the Heart and Its Deficiency Is Causally Related to MalignantHyperthermia-Like Arrhythmia. Sun Z, Wang L, Han L, et al. Circulation. 2021.
5. Safe and efficient magnetic resonanceimaging of acute myocardial infarction with gadolinium-doped carbon dots. Li Y,Li B, Wang X, et al. Nanomedicine. 2020.
6. Connexin 43 dephosphorylation at serine282 is associated with connexin43-mediated cardiomyocyte apoptosis. Yang Y, YanX, Xue J, et al. Cell Death Differ. 2019.
7. Connexin 43 dephosphorylationcontributes to arrhythmias and cardiomyocyte apoptosis in ischemia/ reperfusionhearts. Xue J, Yan X, Yang Y, et al. Basic Res Cardiol. 2019.
8. Connexin 43-serine 282 modulates serine279 phosphorylation in cardiomyocytes. Sun Z, Yang Y, Wu L, et al. BiochemBiophys Res Commun. 2019.
9. MnO nanoparticles with potentialapplication in magnetic resonance imaging and drug delivery for myocardialinfarction. Zheng Y, Zhang H, Hu Y, et al. International Journal ofNanomedicine. 2018.
10. Low molecular weight fucoidanattenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice, Zheng Y, LiuT, Wang Z, et al. Int J Biol Macromol. 2018.
11. Low molecular weight fucoidanameliorates hindlimb ischemic injury in type 2 diabetic rats, Wang Z, Liu T,Chen X, et al. J Ethnopharmacol. 2018.
文件上传中...
